Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joan J. Alberti
Observed names:
Albertí, Joan,
J Alberti,
Joan Alberti,
Joan Albertí,
Joan Albertí,
Joan J. Albertí
show all 6
Institution:
Almirall (Spain)
Observed institutions:
Almirall (Spain),
Parc Científic de Barcelona
OpenAlex ID:
A5036193485
GSSG/GSH ratios in cryopreserved rat and human hepatocytes as a biomarker for drug induced oxidative stress
2014
·
Sonia Sentellas
, Oriol Morales-Ibanez
, et al.
·
Toxicology in Vitro
·
95
Discovery of Novel Quaternary Ammonium Derivatives of (3R)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic Exposure after Inhaled Administration: Identification of (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane Bromide (Aclidinium Bromide)
2009
·
María Prat
, Dolors Fernández
, et al.
·
Journal of Medicinal Chemistry
·
73
Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: In vitro plasma inactivation and pharmacological activity of its main metabolites
2010
·
Sonia Sentellas
, Israel Ramos
, et al.
·
European Journal of Pharmaceutical Sciences
·
71
The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide
2014
·
Amadeu Gavaldà
, Israel Ramos
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
48
Identification of the Human Enzymes Responsible for the Enzymatic Hydrolysis of Aclidinium Bromide
2010
·
Joan Albertí
, Audrey Martinet
, et al.
·
Drug Metabolism and Disposition
·
38
A Novel, Extremely Bioavailable Cocrystal of Pterostilbene
2021
·
Lídia Bofill
, Rafael Barbas
, et al.
·
Crystal Growth & Design
·
36
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases
2019
·
Jordi Bach
, Paul Eastwood
, et al.
·
Journal of Medicinal Chemistry
·
33
Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A2B adenosine receptor antagonists
2010
·
Paul Eastwood
, Jacob Gonzalez
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
20
Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist
2010
·
Paul Eastwood
, Cristina Esteve
, et al.
·
ACS Medicinal Chemistry Letters
·
19
Determination of S-containing drug metabolites from in vitro and in vivo metabolism studies by using LC-ICP/MS
2012
·
Cristina Losada
, Joan J. Albertí
, et al.
·
Analytical and Bioanalytical Chemistry
·
14
Development of a UHPLC method for the assessment of the metabolic profile of cinitapride
2011
·
Helena Marquez
, Joan Albertí
, et al.
·
Journal of Separation Science
·
12
In vitro liver metabolism of aclidinium bromide in preclinical animal species and humans: Identification of the human enzymes involved in its oxidative metabolism
2010
·
Joan J. Albertí
, Sònia Sentellas
, et al.
·
Biochemical Pharmacology
·
12
Final report of a phase I study of 2-hydroxyoleic acid (2OHOA) a novel sphingomyelin synthase activator in patients (pt) with advanced solid tumors (AST) including recurrent high grade gliomas (rHGG).
2017
·
Analia Azaro
, Elizabeth R. Plummer
, et al.
·
Journal of Clinical Oncology
·
8
Pharmacokinetic modeling and simulation of subcutaneous and intravenous IgG dosing in patients with primary immunodeficiency diseases
2022
·
Graciela Navarro-Mora
, Joan J. Alberti
, et al.
·
International Immunopharmacology
·
6
PDF
Characterization of in vitro metabolic profiles of cinitapride obtained with liver microsomes of humans and various mammal species using UHPLC and chemometric methods for data analysis
2012
·
Helena Marquez
, Joan Albertí
, et al.
·
Analytical and Bioanalytical Chemistry
·
4
Liquid chromatography-mass spectrometry as a general approach for investigating covalent binding of drugs to DNA
2016
·
Maria Raja
, Joan Albertí
, et al.
·
Analytical and Bioanalytical Chemistry
·
2
Enzymatic Hydrolysis of Aclidinium Bromide in Human Plasma by Human Esterases.
2009
·
J Alberti
, A Martinet
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Pharmacokinetics and Ex Vivo Activity of 7-Methylxanthine, an Inhibitor of Monosodium Urate Crystallization
2025
·
Miguel D. Ferrer
, Jaume Dietrich
, et al.
·
Biomedicines
·
1
PDF
Abstract 1264: A first-in-class c-MYC inhibitor shows in vivo efficacy in lung cancer models and has appropriate drug-like characteristics
2021
·
Haritz Moreno
, Borja Ruiz Fernández-de-Córdoba
, et al.
·
Cancer Research
·
1
New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats
2014
·
Isabel Ramis
, Elena Calama
, et al.
·
European Respiratory Journal
·
1
Discovery of LAS194046: A Potent and Selective pan-Janus Kinase (JAK) Inhibitor with a Suitable Profile for Inhaled Administration
2026
·
Jordi Bach
, Daniel Pérez
, et al.
·
Journal of Medicinal Chemistry
Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification
2024
·
Joan Perelló
, Joan Alberti
, et al.
·
Frontiers in Pharmacology
PDF
CCDC 2017899: Experimental Crystal Structure Determination
2021
·
Bofill, Lídia
, Barbas, Rafael
, et al.
·
The Cambridge Structural Database
CCDC 2017897: Experimental Crystal Structure Determination
2021
·
Bofill, Lídia
, Barbas, Rafael
, et al.
·
The Cambridge Structural Database
CCDC 2017895: Experimental Crystal Structure Determination
2021
·
Bofill, Lídia
, Barbas, Rafael
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
29
Citation count:
496
H-index:
12
I10-index:
12
Year
Topic
Type
